Biotech

Startups News

Biotech Startups Essentials publishes only the best Biotech news and links, carefully hand-picked and curated by top biotech experts.

Top news of the week: 26.04.2022.

#VC
#biotech
#startups
#IPO
#WuXiHealthcareForum
#behindthepaper
#medicaldevices
#AI
#lifesciences

Startups

@nvca shared
On Apr 22, 2022
4/ #VC leaders in Climate & Sustainability: @ckarapataki specializes in decarbonization solutions for the electricity, transportation, and manufacturing sectors. @Breakthrough, the 2017 @Forbes 30 Under 30 – energy recipient.⬇️ https://t.co/HOwEbC9oCy https://t.co/ZOvukNiRb9
Open
NVCA Celebrates Earth Day with VC Leaders in Climate and Sustainability

NVCA Celebrates Earth Day with VC Leaders in Climate and Sustainability

In honor of Earth Day, we’re recognizing and celebrating five leading VCs in climate and sustainability investing within the NVCA member community. We’re excited to hear from them, ...

@big4bio shared
On Apr 25, 2022
HilleVax sets #IPO terms, valuing the biotech at up to $543 million https://t.co/tlcrLcqJOc $HLVX #biotech
Open
HilleVax sets IPO terms, valuing the biotech at up to $543 million

HilleVax sets IPO terms, valuing the biotech at up to $543 million

HilleVax Inc. undefined has set terms for its initial public offering, in which the Massachusetts-based biopharmaceutical company that focuses on developing...

@BentheFidler shared
On Apr 20, 2022
Satellite Bio launches with new approach to bioengineering tissues https://t.co/nN3qKQNfnd by @NedPagliarulo #biotech #startups $NVS
Open
Satellite Bio launches with new approach to bioengineering tissues

Satellite Bio launches with new approach to bioengineering tissues

Backed by $110 million in venture funding, Satellite is led by Dave Lennon, formerly head of Novartis Gene Therapies. 

@VentureFizz shared
On Apr 25, 2022
Don't miss the latest episode of The @VentureFizz Podcast featuring Rahul Chaturvedi, Founder & CEO of @MeetClora. Topics: drug discovery & clinical trials process; how Clora is helping to solve the talent crisis in the life science industry, and more! https://t.co/XNl6J17RRr
Open
The VentureFizz Podcast: Rahul Chaturvedi - Founder & CEO of Clora

The VentureFizz Podcast: Rahul Chaturvedi - Founder & CEO of Clora

<p>Episode #256 of The VentureFizz Podcast features Rahul Chaturvedi, Founder & CEO of Clora.</p>

@PearlF shared
On Apr 22, 2022
Expanding with new NYC office: @abscibio, founded in '11 w/basement lab in Portland Oregon, opened NYC-based Absci AI Research Lab on Wed & announced NVIDIA collaboration. 43rd floor of Carnegie Hall Tower. Merck is also 1 of $ABSI's collaborators https://t.co/j0KWDAUt3a
Open
Vancouver, Wash.-based biotech Absci opens new AI Research Lab in New York City

Vancouver, Wash.-based biotech Absci opens new AI Research Lab in New York City

Absci, the Vancouver, Wash.-based biotech that provides drug and drug target discovery services to other companies, has opened a lab in New York City. The company announced the opening of ...

@FlagshipPioneer shared
On Apr 22, 2022
Interested in the impact of technologies on treating and preventing illness? Tune in to the #WuXiHealthcareForum keynote by Steve Hahn, Flagship CEO-Partner & CEO of Flagship-founded @HarbingerHlth on 4/26. Register: https://t.co/V2su0VM09m @WuXi_Discovery
Open
WuXi Healthcare Forum 2022

WuXi Healthcare Forum 2022

Join thousands from around the world online this April 26-28 for the complimentary global WuXi Healthcare Forum 2022.

@NatureBiotech shared
On Apr 21, 2022
@cambridgelaw @mateo_aboy Lead author @mateo_aboy goes #behindthepaper on finding that obtaining European patent protection for medical uses of known products is not a key factor limiting repurposing activity https://t.co/oHj0CLSbro
Open
European patent protection for medical uses of known products and drug repurposing

European patent protection for medical uses of known products and drug repurposing

Obtaining European patent protection for medical uses of known products is not a key factor limiting repurposing activity.

@big4bio shared
On Apr 20, 2022
RT @biostartupnews: Here's the latest edition of BioStartup News! Catch the most recent updates going on with life science #startups across the US! April 20: Executive Hires; BioXcel's $260M Financing; TG Disbands Cancer Program https://t.co/G2i1cuhSF7 #lifesciences #biotech #medicaldevices #AI https://t.co/ydXszBmjGd
Open
MISPRO OPENS NEW CONTRACT VIVARIUM FACILITY IN LONG ISLAND CITY, NEW YORK’S NEWEST BIOTECH DESTINATION Learn More

MISPRO OPENS NEW CONTRACT VIVARIUM FACILITY IN LONG ISLAND CITY, NEW YORK’S NEWEST BIOTECH DESTINATION Learn More

BioXcel Therapeutics: Formation of OnkosXcel Therapeutics to Develop Medicines Focused in Oncology More Consegna Pharma: Acquires Fathom Pharma to Strengthen Initiatives that …